Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is to evaluate the efficacy and safety of M518101 and the dose relationship among
two doses of M518101 and placebo in male and female plaque psoriasis patients.